Skip to main content
Caplight Logo









Symbiotic Capital

Symbiotic Capital

Los Angeles, Californiasymbcap.com

Overview

A global life science credit firm that provides lending solutions and non-dilutive capital to support the growth of established, late-stage companies across biotechnology, medical devices, diagnostics, tools, synthetic biology, and other healthcare subsectors. Affiliated with Bellco Capital, the firm was founded by Dr. Arie Belldegrun.

Portfolio Companies

4

Investments

Symbiotic Capital investments
CompanyDateStageLead
TARGANMar 2026Growth EquityLead
TARGANDec 2025Growth EquityLead
CaresyntaxAug 2024Debt-
AccelusJan 2024DebtLead
Cleveland DiagnosticsJan 2024Series ECo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLos Angeles, California
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?